Corteva, Inc. (NYSE:CTVA) Shares Sold by Janney Montgomery Scott LLC

Janney Montgomery Scott LLC decreased its holdings in Corteva, Inc. (NYSE:CTVA) by 0.2% during the 3rd quarter, according to the company in its most recent disclosure with the SEC. The fund owned 102,157 shares of the company’s stock after selling 193 shares during the quarter. Janney Montgomery Scott LLC’s holdings in Corteva were worth $6,006,000 as of its most recent SEC filing.

Several other institutional investors also recently modified their holdings of CTVA. Duality Advisers LP increased its stake in shares of Corteva by 30.2% in the first quarter. Duality Advisers LP now owns 17,846 shares of the company’s stock worth $1,029,000 after acquiring an additional 4,142 shares during the last quarter. Envestnet Portfolio Solutions Inc. lifted its stake in Corteva by 6.9% in the first quarter. Envestnet Portfolio Solutions Inc. now owns 79,971 shares of the company’s stock valued at $4,612,000 after acquiring an additional 5,142 shares during the last quarter. Empowered Funds LLC grew its position in Corteva by 55.4% in the first quarter. Empowered Funds LLC now owns 16,804 shares of the company’s stock worth $969,000 after acquiring an additional 5,989 shares in the last quarter. SG Americas Securities LLC increased its stake in shares of Corteva by 279.5% during the 1st quarter. SG Americas Securities LLC now owns 120,952 shares of the company’s stock worth $6,975,000 after purchasing an additional 89,077 shares during the last quarter. Finally, Oppenheimer Asset Management Inc. lifted its stake in shares of Corteva by 1.3% in the 1st quarter. Oppenheimer Asset Management Inc. now owns 24,212 shares of the company’s stock valued at $1,396,000 after purchasing an additional 305 shares during the last quarter. Institutional investors own 81.54% of the company’s stock.

Corteva Price Performance

Shares of CTVA stock opened at $58.33 on Friday. The firm has a fifty day moving average of $58.19 and a 200-day moving average of $55.59. The company has a quick ratio of 1.17, a current ratio of 1.72 and a debt-to-equity ratio of 0.10. The firm has a market capitalization of $40.38 billion, a price-to-earnings ratio of 44.87, a price-to-earnings-growth ratio of 1.76 and a beta of 0.77. Corteva, Inc. has a 12-month low of $43.22 and a 12-month high of $63.75.

Corteva (NYSE:CTVA) last issued its quarterly earnings data on Wednesday, November 6th. The company reported ($0.49) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.31) by ($0.18). Corteva had a net margin of 5.31% and a return on equity of 7.30%. The business had revenue of $2.33 billion during the quarter, compared to analyst estimates of $2.69 billion. On average, equities research analysts forecast that Corteva, Inc. will post 2.66 earnings per share for the current year.

Corteva Announces Dividend

The company also recently announced a quarterly dividend, which will be paid on Monday, December 16th. Investors of record on Monday, December 2nd will be given a $0.17 dividend. This represents a $0.68 dividend on an annualized basis and a yield of 1.17%. The ex-dividend date of this dividend is Monday, December 2nd. Corteva’s dividend payout ratio is presently 52.31%.

Analyst Upgrades and Downgrades

A number of brokerages have weighed in on CTVA. Barclays boosted their price target on Corteva from $58.00 to $62.00 and gave the stock an “equal weight” rating in a research report on Friday. Citigroup initiated coverage on shares of Corteva in a research report on Wednesday, October 23rd. They set a “buy” rating and a $68.00 target price for the company. UBS Group lifted their price objective on Corteva from $67.00 to $71.00 and gave the stock a “buy” rating in a research note on Thursday. Bank of America upgraded Corteva from a “neutral” rating to a “buy” rating and increased their target price for the company from $59.00 to $67.00 in a research note on Wednesday, October 16th. Finally, KeyCorp dropped their price target on Corteva from $66.00 to $62.00 and set an “overweight” rating on the stock in a research report on Friday, August 2nd. One analyst has rated the stock with a sell rating, five have given a hold rating and fifteen have issued a buy rating to the stock. Based on data from MarketBeat.com, Corteva currently has a consensus rating of “Moderate Buy” and an average target price of $63.47.

Corteva Company Profile

Corteva, Inc operates in the agriculture business. It operates through two segments, Seed and Crop Protection. The Seed segment develops and supplies advanced germplasm and traits that produce optimum yield for farms. It offers trait technologies that enhance resistance to weather, disease, insects, and herbicides used to control weeds, as well as food and nutritional characteristics.